AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Novel method for treating chronic neuropathic pain with propofol derivatives

Summary
Gareth R. Tibbs, Ph.D.; Peter Goldstein, M.D.;Pamela Flood, M.D.
Technology Benefits
Drug class demonstrated clinically to be safeNovel target for neuropathic painIn vivo demonstration of efficacyPatent information:Patent Pending (WO/2011/019747)
Technology Application
Neuropathic back painDiabetic neuropathyPost-herpetic neuralgiaHIV neuropathyTrigeminal neuralgia
Detailed Technology Description
Lead Inventors: Gareth R. Tibbs, Ph.D.; Peter Goldstein, M.D.;Pamela Flood, M.D.
*Abstract
None
*Inquiry
Cynthia LangColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu
*IR
2605
*Principal Investigator
*Publications
G.R. Tibbs et al. HCN1 Channels as Targets for Anesthetic and Nonanesthetic Propofol Analogs in the Amelioration of Mechanical and Thermal Hyperalgesia in a Mouse Model of Neuropathic Pain, Vol. 345, Issue 3, June 2013, pp. 363-373.
Country/Region
USA

For more information, please click Here
Mobile Device